|
Puma Biotechnology, Inc. (PBYI) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Puma Biotechnology, Inc. (PBYI) Bundle
Optimieren Sie Ihre Zeit und verbessern Sie die Präzision mit unserem [PBYI] DCF -Taschenrechner! Ausgestattet mit echten Daten von Puma Biotechnology, Inc. und anpassbaren Annahmen ermöglicht es Ihnen, [Unternehmen] als erfahrene Investor zu prognostizieren, zu analysieren und zu bewerten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 225.1 | 253.2 | 228.0 | 235.6 | 230.5 | 232.6 | 234.7 | 236.9 | 239.1 | 241.3 |
| Revenue Growth, % | 0 | 12.48 | -9.95 | 3.35 | -2.19 | 0.92167 | 0.92167 | 0.92167 | 0.92167 | 0.92167 |
| EBITDA | -38.5 | -5.4 | 21.0 | 47.5 | 31.0 | 11.0 | 11.1 | 11.2 | 11.3 | 11.4 |
| EBITDA, % | -17.12 | -2.13 | 9.2 | 20.17 | 13.44 | 4.71 | 4.71 | 4.71 | 4.71 | 4.71 |
| Depreciation | 7.2 | 10.6 | 8.9 | 11.5 | .0 | 7.5 | 7.6 | 7.7 | 7.7 | 7.8 |
| Depreciation, % | 3.2 | 4.19 | 3.91 | 4.89 | 0 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 |
| EBIT | -45.7 | -16.0 | 12.0 | 36.0 | 31.0 | 3.4 | 3.5 | 3.5 | 3.5 | 3.6 |
| EBIT, % | -20.32 | -6.32 | 5.28 | 15.28 | 13.44 | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 |
| Total Cash | 85.3 | 63.1 | 76.2 | 95.9 | 101.0 | 84.1 | 84.9 | 85.6 | 86.4 | 87.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 25.5 | 32.5 | 40.4 | 48.5 | 32.0 | 35.5 | 35.8 | 36.2 | 36.5 | 36.8 |
| Account Receivables, % | 11.35 | 12.85 | 17.7 | 20.58 | 13.89 | 15.27 | 15.27 | 15.27 | 15.27 | 15.27 |
| Inventories | 3.5 | 7.1 | 4.5 | 7.1 | 8.7 | 6.1 | 6.2 | 6.2 | 6.3 | 6.3 |
| Inventories, % | 1.53 | 2.81 | 1.99 | 3 | 3.79 | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 |
| Accounts Payable | 12.1 | 11.2 | 6.4 | 6.9 | 5.5 | 8.3 | 8.4 | 8.5 | 8.6 | 8.6 |
| Accounts Payable, % | 5.36 | 4.41 | 2.82 | 2.92 | 2.39 | 3.58 | 3.58 | 3.58 | 3.58 | 3.58 |
| Capital Expenditure | -20.0 | .0 | -7.0 | -12.6 | -.1 | -8.1 | -8.2 | -8.2 | -8.3 | -8.4 |
| Capital Expenditure, % | -8.91 | 0 | -3.07 | -5.36 | -0.02429838 | -3.47 | -3.47 | -3.47 | -3.47 | -3.47 |
| Tax Rate, % | -25.63 | -25.63 | -25.63 | -25.63 | -25.63 | -25.63 | -25.63 | -25.63 | -25.63 | -25.63 |
| EBITAT | -45.9 | -16.2 | 22.0 | 34.3 | 38.9 | 3.4 | 3.4 | 3.5 | 3.5 | 3.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -75.7 | -17.1 | 13.9 | 22.9 | 52.3 | 4.8 | 2.6 | 2.6 | 2.6 | 2.6 |
| WACC, % | 7.95 | 7.95 | 7.95 | 7.91 | 7.95 | 7.94 | 7.94 | 7.94 | 7.94 | 7.94 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 12.4 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 3 | |||||||||
| Terminal Value | 55 | |||||||||
| Present Terminal Value | 37 | |||||||||
| Enterprise Value | 50 | |||||||||
| Net Debt | -17 | |||||||||
| Equity Value | 67 | |||||||||
| Diluted Shares Outstanding, MM | 49 | |||||||||
| Equity Value Per Share | 1.36 |
What You Will Receive
- Authentic PBYI Financial Data: Pre-filled with Puma Biotechnology’s historical and projected figures for accurate analysis.
- Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA %.
- Instant Calculations: Witness PBYI’s intrinsic value update in real-time as you make changes.
- Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- Intuitive Design: Clear layout and straightforward instructions suitable for all skill levels.
Key Features
- Real-Life PBYI Data: Pre-filled with Puma Biotechnology’s historical financials and forward-looking projections.
- Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
- Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
- Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
- User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.
How It Works
- 1. Download the Template: Obtain and open the Excel file featuring Puma Biotechnology, Inc.'s (PBYI) preloaded data.
- 2. Adjust Assumptions: Modify key variables such as growth rates, WACC, and capital expenditures.
- 3. View Immediate Results: The DCF model calculates intrinsic value and NPV in real-time.
- 4. Explore Different Scenarios: Analyze various forecasts to evaluate different valuation outcomes.
- 5. Present with Assurance: Share professional valuation insights to back your strategic decisions.
Why Choose This Calculator for Puma Biotechnology, Inc. (PBYI)?
- Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and industry consultants.
- Accurate Data: Puma Biotechnology’s historical and projected financials are preloaded for precision.
- Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Detailed Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.
Who Should Use This Product?
- Investors: Evaluate Puma Biotechnology’s valuation before making stock transactions.
- CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
- Startup Founders: Understand the valuation strategies of established biotech firms like Puma Biotechnology.
- Consultants: Create detailed valuation reports for your clients in the biotech sector.
- Students and Educators: Utilize current data to explore and teach valuation principles.
What the Template Contains
- Pre-Filled Data: Includes Puma Biotechnology’s historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations tailored for (PBYI).
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on customized inputs for (PBYI).
- Key Financial Ratios: Analyze Puma Biotechnology’s profitability, efficiency, and leverage.
- Customizable Inputs: Easily edit revenue growth, margins, and tax rates specific to (PBYI).
- Clear Dashboard: Charts and tables summarizing key valuation results for (PBYI).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.